Clinical Trial: Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
Brief Summary: The purpose of this study is to determine if cardizem is effective in the treatment of nitric oxide non-responder pulmonary arterial hypertension.
Detailed Summary:
Sponsor: University of South Florida
Current Primary Outcome: Six Minute Walk Distance [ Time Frame: 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Dyspnea Score [ Time Frame: 12 weeks ]
- Quality of Life Score [ Time Frame: 12 weeks ]
- Pulse Oximetry [ Time Frame: 12 weeks ]
Original Secondary Outcome: Same as current
Information By: University of South Florida
Dates:
Date Received: October 18, 2011
Date Started: July 2012
Date Completion: November 2014
Last Updated: September 6, 2013
Last Verified: September 2013
